Poly(lactic-co-glycolic acid) (PLGA) nanoparticles constitute a versatile and biocompatible platform for controlled drug delivery. Their degradation rate and mechanical properties can be tuned by ...

The biodegradable polymer Poly (D,L-lactide-co-glycolic acid) (PLGA) is widely regarded as safe for use in medical applications, seeing common use in the creation of particles used in in vivo studies.

The rapid evolution of nanomedicine has elevated drug delivery from a formulation challenge to a critical factor determining therapeutic success. Whether developing mRNA vaccines, cancer therapeutics, ...

Purdue University researchers are developing and validating patent-pending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine triphosphate, or ATP, to enhance immunotherapy ...

Scientists at Xi’an Jiaotong-Liverpool University (XJTLU) and at Nanjing University have combined a widely used medical polymer with a natural blood protein to develop a new nanoparticle drug delivery ...